A Study of Oral Contraception Under Simulated OTC Conditions

Stopped early · Phase 3

Conditions studied: Contraception

In brief

This study is designed to assess whether consumers select and use norgestrel 0.075 mg, a progestin only pill for contraception, in a manner consistent with the OTC package directions in an Over-the-Counter (OTC)-like setting.

Key facts

Study ID

NCT03559010

Run by

HRA Pharma

People needed

189

Starts

2018-04-27

Expected to finish

2018-11-14

Last updated by the study team

2022-04-04

Who can join

Age: 12 and older. Sex: female. Healthy volunteers: accepted.

You may qualify if…

• Women who are willing purchase (in the pharmacies) or be provided (in the clinics) oral contraception for their own use for the purposes of the study

You may not qualify if…

• Cannot read, speak and understand English
• Cannot see well enough to read information on the label

Where it is running

• HRA Pharma Investigational site — Birmingham, Alabama, United States
• HRA Pharma Investigational site — Homewood, Alabama, United States
• HRA Pharma Investigational site — McCalla, Alabama, United States
• HRA Pharma Investigational site — Tucson, Arizona, United States
• HRA Pharma Investigational site — Downey, California, United States
• HRA Pharma Investigational site — La Habra, California, United States
• HRA Pharma Investigational site — Long Beach, California, United States
• HRA Pharma Investigational site — Los Angeles, California, United States
• HRA Pharma Investigational site — Bridgeport, Connecticut, United States
• HRA Pharma Investigational site — Hartford, Connecticut, United States
• HRA Pharma Investigational site — New Haven, Connecticut, United States
• HRA Pharma Investigational site — Riverview, Florida, United States
• HRA Pharma Investigational site — Dalton, Georgia, United States
• HRA Pharma Investigational site — Griffin, Georgia, United States
• HRA Pharma Investigational site — Catonsville, Maryland, United States
• HRA Pharma Investigational site — Anoka, Minnesota, United States
• HRA Pharma Investigational site — Elk River, Minnesota, United States
• HRA Pharma Investigational site — Fridley, Minnesota, United States
• HRA Pharma Investigational Site — Saint Francis, Minnesota, United States
• HRA Pharma Investigational site — Elsberry, Missouri, United States
• HRA Pharma Investigational site — Manchester, Missouri, United States
• HRA Pharma Investigational Site — Savannah, Missouri, United States
• HRA Pharma Investigational site — Springfield, Missouri, United States
• HRA Pharma Investigational site — Monroe, New Jersey, United States
• HRA Pharma Investigational site — Albuquerque, New Mexico, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.